WilsonHCG Recognized as a “Leader” for RPO in NelsonHall's NEAT Vendor Evaluation
Wilson Human Capital Group, Inc. (WilsonHCG), the premium provider and global leader in innovative talent solutions, has been recognized as a “Leader” in NelsonHall’s NEAT vendor evaluation for RPO. WilsonHCG was identified as a Leader in NelsonHall’s NEAT vendor evaluation for each category – including Overall, Global/Multi-Country Focus, and most notably both Innovation and Candidate Experience.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180228005096/en/
Regarding WilsonHCG’s placement, Nikki Edwards, Principal HR Services Research Analyst with NelsonHall said, “WilsonHCG is positioned as a Leader for their ability to be innovative and create/deliver a high-touch candidate and customer focused experience. This is backed by strong client marks in several areas including: ability to scale up and down; improved quality of hire; use of analytics; and strength of partnership.”
“It’s an honor to again receive a Leader recognition in the Innovation and Candidate Experience categories, as each are integral to providing our clients with the service they deserve,” WilsonHCG CEO John Wilson said. “In meeting with business leaders across the globe, they’re seeking ‘innovative’ RPO providers; WilsonHCG’s consistent recognition in this category by NelsonHall is evidence of our people, the solutions we provide, and the ways in which we bring better talent to our partners."
WilsonHCG’s NelsonHall recognition comes on the heels of a 2017 that included being named to HRO Today’s EMEA Baker’s Dozen Customer Satisfaction List for the third consecutive year, a top RPO provider in the global Baker’s Dozen List for seven consecutive years, and a STAR performer in Everest Group's Global RPO Peak Matrix report for three consecutive years.
About NelsonHall and NEAT vendor evaluation
NelsonHall is the leading global analyst firm dedicated to helping organizations understand the 'art of the possible' in IT and business services with analysts in the U.S., U.K., and Continental Europe. NelsonHall provides buy-side organizations with detailed, critical information on markets and vendors that helps them make fast and highly informed sourcing decisions. And for vendors, NelsonHall provides deep knowledge of market dynamics and user requirements to help them hone their go-to-market strategies.
NEAT is NelsonHall's vendor evaluation and assessment tool, a method by which sourcing managers can strategically evaluate vendors at the onset of the screening process. Positioning as a "Leader" is based on a combination of analyst assessments and feedback from interviewing of vendor clients, primarily around measurements of the vendor’s ability to deliver immediate benefit as well as meeting future customer requirements.
Wilson Human Capital Group, Inc., (WilsonHCG) is the premium provider and global leader in innovative talent solutions that operates on the principle of providing true partnership to our clients. Through our highly configurable Talent Ecosystem™ model, we enhance the talent function into a strategic advantage. At WilsonHCG, the relationships we develop lead to the results our clients realize. Better People, Better Business.®
Wilson Human Capital Group, Inc.
Richard Ward, 1.715.214.9144
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
VERTEX-PHARMACEUTICALS19.10.2018 13:56 | pressemeddelelse
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene
TX-SCHLUMBERGER-LIMITED19.10.2018 13:02 | pressemeddelelse
Schlumberger Announces Third-Quarter 2018 Results
CA-TRADESHIFT19.10.2018 13:02 | pressemeddelelse
Tradeshift Announces Q3 2018 Results
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum